Abstract
The standard version of the wing somatic mutation and recombination test (SMART) in Drosophila melanogaster was employed in order to evaluate the genotoxic potential of metronidazole (MTZ) as a function of exposure concentration. MTZ was administered by chronic feeding of 3-day-old larvae with the parenteral solution at 0, 500, 1000 and 2000 μg/ml until pupation. The marker-heterozygous progeny (mwh+/+flr3) with phenotypically wild-type wings was analyzed. Non significant differences were found between control and each MTZ concentration tested for single small spots (SSS) frequencies. Large single spots (LSS) and twin spots (TS) were significantly increased with the higher dose. MTZ treatments with 1000 and 2000 μg/ml also significantly increased the frequency of Total spots. These findings suggest that MTZ is genotoxic in the present experimental conditions and induces recombinagenesis and/or gene conversion, two major mechanisms that cause loss of heterocigosity and could play an important role in tumorigenesis and carcinogenesis processes.
Keywords: Drosophila, genotoxicity, metronidazole (MTZ), loss of heterozygosity, wing spot assay.
Current Drug Safety
Title:Metronidazole Induced DNA Damage in Somatic Cells of Drosophila melanogaster
Volume: 8 Issue: 3
Author(s): Ana Maria Palermo and Marta Dolores Mudry
Affiliation:
Keywords: Drosophila, genotoxicity, metronidazole (MTZ), loss of heterozygosity, wing spot assay.
Abstract: The standard version of the wing somatic mutation and recombination test (SMART) in Drosophila melanogaster was employed in order to evaluate the genotoxic potential of metronidazole (MTZ) as a function of exposure concentration. MTZ was administered by chronic feeding of 3-day-old larvae with the parenteral solution at 0, 500, 1000 and 2000 μg/ml until pupation. The marker-heterozygous progeny (mwh+/+flr3) with phenotypically wild-type wings was analyzed. Non significant differences were found between control and each MTZ concentration tested for single small spots (SSS) frequencies. Large single spots (LSS) and twin spots (TS) were significantly increased with the higher dose. MTZ treatments with 1000 and 2000 μg/ml also significantly increased the frequency of Total spots. These findings suggest that MTZ is genotoxic in the present experimental conditions and induces recombinagenesis and/or gene conversion, two major mechanisms that cause loss of heterocigosity and could play an important role in tumorigenesis and carcinogenesis processes.
Export Options
About this article
Cite this article as:
Palermo Maria Ana and Mudry Dolores Marta, Metronidazole Induced DNA Damage in Somatic Cells of Drosophila melanogaster, Current Drug Safety 2013; 8 (3) . https://dx.doi.org/10.2174/15748863113089990035
DOI https://dx.doi.org/10.2174/15748863113089990035 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Summary of Electrospun Nanofibers as Drug Delivery System: Drugs Loaded and Biopolymers Used as Matrices
Current Drug Delivery Gymnema sylvestre R. Br., an Indian Medicinal Herb: Traditional Uses, Chemical Composition, and Biological Activity
Current Pharmaceutical Biotechnology Capsaicin and Its Analogues: Structure-Activity Relationship Study
Current Medicinal Chemistry Proinflammatory Cytokines in Breast Cancer: Mechanisms of Action and Potential Targets for Therapeutics
Current Drug Targets Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer
Current Chemical Biology Implication of Rho GTPases in Neurodegenerative Diseases
Current Drug Targets Caveolin-1: A Promising Therapeutic Target for Diverse Diseases
Current Molecular Pharmacology Advances in Hyaluronic Acid-Based Drug Delivery Systems
Current Drug Targets Autoimmune Channelopathies of the Nervous System
Current Neuropharmacology Comparative Anatomy, Physiology and In Vitro Models of the Blood-Brain and Blood-Retina Barrier
Current Medicinal Chemistry - Central Nervous System Agents MiRNA-29: A microRNA Family with Tumor-Suppressing and Immune-Modulating Properties
Current Molecular Medicine Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review
Current Drug Therapy Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
Current Topics in Medicinal Chemistry AFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species
Current Pharmaceutical Design Sauropus androgynus Leaves for Health Benefits: Hype and the Science
The Natural Products Journal Staphylococcus aureus: The Toxic Presence of a Pathogen Extraordinaire
Current Medicinal Chemistry Berberine: A Fluorescent Alkaloid with a Variety of Applications from Medicine to Chemistry
Mini-Reviews in Organic Chemistry Biosafety of Recombinant Adeno-associated Virus Vectors
Current Gene Therapy Caffeine and Suicide: A Systematic Review
CNS & Neurological Disorders - Drug Targets Fibroblast Activation Protein in Remodeling Tissues
Current Molecular Medicine